← Eichor
Study identifier: NCT05257161 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Carotid Revascularization With MicroNet Covered Stent Comparing Early Neurological Outcomes With Distal Versus Proximal EPS

Condition: Patients With Aterosclerotic Carotid Stenosis · Symptomatic Patients (Stenosis > 50%) · Asymptomatic Patients (Stenosis ≥80%)  ·  Sponsor: Meshalkin Research Institute of Pathology of Circulation

PhaseNA
Planned participants366
Who can joinAll sexes, 45 Years to 80 Years
Healthy volunteersNo

About this study

The SIBERIA study demonstrated a clear advantage of CGuard stent implantation over the existing classical stent when using a distal anti-embolic device. At the same time, there is no Level 1 evidence for a difference between the proximal and distal anti-embolic device for the CGuard stent.

This description comes directly from the study's public registry record.

Talk to the study team

Andrey A Kaprenko, MD  ·  +79139504100  ·  a_karpenko@meshalkin.ru

Always discuss trial participation with your own doctor first.

Locations (1)

E. Meshalkin National Medical Research CenterNovosibirsk, RussiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05257161